Blood filtering with Oxiris for septic shock
Part of Infections clinical trials.
This study tests a special blood-filtering treatment (called Oxiris) for people with septic shock, a life-threatening condition where infection causes very low blood pressure. The goal is to see if this treatment can safely improve recovery. If you are already receiving CRRT, this may help your blood get cleaner and your pressure more stable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years of age or older.
- You have septic shock (a severe infection that causes very low blood pressure).
- Your doctor has decided that you need blood purification therapy (like CRRT).
- You do not have a 'do not resuscitate' order and are expected to live more than 24 hours.
- You are not pregnant or breastfeeding.
- You are not allergic to heparin or the materials in the Oxiris filter.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special blood filtering device (OXiris) in patients with severe abdominal infections and septic shock. The filter may help remove harmful substances from the blood and support kidney function, potentially improving recovery.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This study looks back at how a special kidney filter called oXiris helped patients in the ICU who had septic shock (a life-threatening blood infection) and kidney failure. Researchers want to understand if this filter improved survival and recovery compared to standard treatment.
This study tests whether using a special filter (oXiris) during dialysis can better remove harmful toxins from the blood in people with septic shock and kidney failure, potentially helping them recover faster.
This study tests a blood-filtering treatment for people with septic shock, a severe infection that causes very low blood pressure. The treatment aims to remove harmful substances from the blood to help patients recover.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.